Key statistics
As of last trade, Adaptive Biotechnologies Corp (1HM:BER) traded at 4.18, 91.43% above the 52 week low of 2.18 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.18 |
---|---|
High | 4.18 |
Low | 4.18 |
Bid | 4.03 |
Offer | 4.31 |
Previous close | 4.19 |
Average volume | 176.11 |
---|---|
Shares outstanding | 147.58m |
Free float | 144.63m |
P/E (TTM) | -- |
Market cap | 644.92m USD |
EPS (TTM) | -1.34 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:11 GMT.
More ▼
Announcements
- Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results
- Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
- Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024
- Adaptive Announces IVDR Certification for clonoSEQ® in European Union
- Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
- Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
- Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
- Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
More ▼